Effect of Transcranial Direct Current Stimulation (tDCS) and Probiotic Supplementation in Overweight Adults
Comparing the Effectiveness of Transcranial Direct Stimulation (tDCS) and Probiotic Supplementation on Risky Decision-making, Impulsivity, Self-control, and Food Selection in Overweight Adults
1 other identifier
interventional
60
1 country
1
Brief Summary
The aim of the current study is to investigate and compare the effectiveness of probiotic supplementation and tDCS stimulation on risky decision-making related to food choices in overweight people. Considering the relatively established communication and interaction between the gut-brain-microbiome axis, the investigators expect that transcranial direct current stimulation and probiotic supplementation can both improve decision-making (decrease risky and impulsive decisions) and increase self-control in overweight people.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2023
CompletedFirst Submitted
Initial submission to the registry
September 6, 2023
CompletedFirst Posted
Study publicly available on registry
September 13, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2024
CompletedNovember 28, 2023
November 1, 2023
1.3 years
September 6, 2023
November 27, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Body analysis test
This is a technique to determine the percentage of body mass that is fat compared to muscle. It can also indicate where the fat and muscle are carried within the body.
Depending on the experimental group: 10 stimulation days in tDCS groups and 30 days in the probiotic group.
Impulsive Behavior Scale Questionnaire measuring Urgency, Premeditation (lack of), Perseverance (lack of), and Sensation seeking (UPPS)
This is a self-report tool that assesses five subscales (urgency, premeditation, perseverance, sensation seeking, and positive urgency) that are used to measure five distinct dimensions of impulsive behavior; each scale ranging from 4 to 16); Higher scores represent worse outcome.
Depending on the experimental group: 10 stimulation days in tDCS groups and 30 days in the probiotic group.
Eating attitudes Test (EAT-26)
This tool is used to identify the presence of "eating disorder risk" based on attitudes, feelings and behaviours related to eating. The total score (between 0 and 78) provides an overall risk score, where higher scores indicating greater risk of an eating disorder.
Depending on the experimental group: 10 stimulation days in tDCS groups and 30 days in the probiotic group.
Balloon analogue risk task (BART)
BART is a computerized decision-making task that is used to assess risk-taking behavior. The BART simulates a real-world situation, involving actual risky behavior, where taking a risk up until a certain point yields a reward.
Depending on the experimental group: 10 stimulation days in tDCS groups and 30 days in the probiotic group.
Tangney self-control questionnaire (Form 36)
This is a self-report measurement to assess individual differences in traits of self-control. Scores range from 0 to 144 with higher scores representing worse outcome.
Depending on the experimental group: 10 stimulation days in tDCS groups and 30 days in the probiotic group.
Study Arms (4)
Active tDCS over the dorsolateral prefrontal cortex (DLPFC)
EXPERIMENTALIn this group, participants will receive active 2 milliampere (mA) tdcs over the DLPFC (anode on F3 and cathode onF4) for 20 minutes.
Active tDCS over the ventromedial prefrontal cortex (VMPFC)
ACTIVE COMPARATORIn this group, participants will receive active 2 mA tdcs over the VMPFC (anode on Fpz and cathode on Cz) for 20 minutes.
Sham tDCS Stimulation
SHAM COMPARATORIn this group, participants will receive sham tDCS which will ramp up for 30 s at the beginning of the session and then ramp down and be switched off during the 20-minute stimulation session.
Probiotic supplementation
ACTIVE COMPARATORIn this group, participants will consume 2 probiotic supplements (The synbiotics family) daily, for one month.
Interventions
By a probiotic blend capsule a specific product is intended which contains the following: Lactobacillus rhamnosus Lactobacillus plantarum Lactobacillus casei Lactobacillus helveticus Lactobacillus acidophilus Lactobacillus bulgaricus Lactobacillus gasseri Bifidobacterium bifidum Bifidobacterium lactis Bifidobacterium breve Bifidobacterium longum Streptococcus thermophile Fructooligosaccharides (FOS).
Using a tDCS device, a mild direct electric current is going to be non-invasively administered to the brain using rubber electrodes placed over the scalp.
Using a tDCS device, a mild direct electric current is going to be non-invasively administered to the brain using rubber electrodes placed over the scalp. At this arm the electric current will be applied for a very short time (30 s) after which the device will turn off, thus providing the initial tingling sensation over the scalp but not interfering with the ongoing brain activity.
Eligibility Criteria
You may qualify if:
- BMI over 25
- Higher than normal fat level
You may not qualify if:
- Pregnancy
- Breastfeeding
- Smoking more than 10 cigarettes a day
- Excessive consumption of alcohol
- Suffering from chronic cardiovascular and kidney diseases
- Chronic digestive diseases such as celiac disease,
- Chronic inflammatory bowel diseases such as colitis, intestinal surgery, cancer, etc.
- Suffering from acute and chronic diarrhea in the last one month
- Taking antibiotics in two months before the start of the study,
- Continuous use of prebiotic and probiotic products and drugs in one month before the start of the intervention
- Frequent use of antibiotics during the last month before the start of the intervention
- Taking weight loss medications and following a special slimming diet in the last 3 months before the intervention.
- History of epilepsy and seizures, stroke,
- Use of pacemaker
- Presence of metal implanted in the scalp or brain,
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Tehranlead
- University of Messinacollaborator
- Tabriz Universitycollaborator
Study Sites (1)
Atieh neuroscience center
Tehran, 1969713663, Iran
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Marzieh Heysiattalab, PhD
University of Tabriz
- STUDY DIRECTOR
Reza Kazemi, PhD
University of Tehran
- PRINCIPAL INVESTIGATOR
Sara Derafsheh, MSC
University of Tabriz
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant professor
Study Record Dates
First Submitted
September 6, 2023
First Posted
September 13, 2023
Study Start
March 1, 2023
Primary Completion
July 1, 2024
Study Completion
September 1, 2024
Last Updated
November 28, 2023
Record last verified: 2023-11
Data Sharing
- IPD Sharing
- Will not share